Canada markets closed

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
87.80+0.40 (+0.46%)
At close: 05:22PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
121,183
121,183
65,820
44,672
72,230
Selling General and Administrative
13,511
13,511
-
-
-
Total Operating Expenses
134,617
134,617
65,808
44,578
71,918
Operating Income or Loss
-134,617
-134,617
-65,808
-44,578
-71,918
Interest Expense
0
0
293
413
303
Income Before Tax
-123,068
-123,068
-65,451
-44,991
-72,007
Income from Continuing Operations
-123,068
-123,068
-65,451
-44,991
-72,007
Net Income
-123,068
-123,068
-65,451
-44,991
-72,007
Net Income available to common shareholders
-123,068
-123,068
-65,451
-44,991
-72,007
Basic EPS
-5.83
-9.95
-5.83
-4.01
-6.41
Diluted EPS
-5.83
-9.95
-5.83
-4.01
-6.41
Basic Average Shares
11,226
12,365
11,226
11,226
11,226
Diluted Average Shares
11,226
12,365
11,226
11,226
11,226